Stock Market & Financial Investment News

News Breaks December 12, 2012 18:44 EDT KV.A, HOLX KV Pharmaceutical secures $85M loan for payments under reorganization plan K-V Pharmaceutical announced that it has received a commitment from lenders led by an affiliate of Silver Point Finance for $85M in senior secured post-petition debtor-in-possession financing, which the company intends to use to, among other things, satisfy the terms of its recently filed settlement agreement with Hologic (HOLX), provide additional financial flexibility during the pendency of the company's Chapter 11 proceeding and fund certain payments under a proposed reorganization plan. The new DIP financing, the Hologic Settlement and the reorganization plan are each subject to approval of the U. S. Bankruptcy Court for the Southern District of New York. The Hologic settlement confirms K-V's continued ownership of Makena and will resolve all bankruptcy related disputes between K-V and Hologic, and provides for mutual releases of all claims between the parties. Under the proposed reorganization plan, K-V expects to emerge from Chapter 11 with its entire product portfolio, including Makena, Clindesse, Gynazole-1 and Evamist. News For A;HOLX From The Last 14 Days Check below for free stories on A;HOLX the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 23, 2013 10:37 EDT HOLX Hologic 3D mammography technology reduces recall rates, aids detection Subscribe for More Information May 22, 2013 10:16 EDT HOLX Hologic management to meet with Lazard Capital Group dinner to be held in Boston on May 29 hosted by Lazard Capital. May 21, 2013 08:17 EDT HOLX Hologic receives FDA approval for low-dose 3D mammography solution Hologic announced that the FDA approved the use of Hologic's new C-View 2D imaging software. C-View 2D images may now be used in place of the conventional 2D exposure previously required as part of a Hologic 3D mammography screening exam. May 20, 2013 12:20 EDT A Options with decreasing implied volatility: RFMD TTWO LO DDS A May 17, 2013 11:59 EDT A Options with decreasing implied volatility: ILMN LO A HES INFY CSCO May 16, 2013 11:33 EDT A Options with decreasing implied volatility: PANL CSC FTK A NVDA Subscribe for More Information May 15, 2013 14:02 EDT HOLX Leerink's medical devices analyst holds a conference call Medical Devices Analyst Newitter discusses Hologic's tomosynthesis (3D) technology on an Analyst/Industry conference call to be held on May 16 at 2:30 pm. 11:42 EDT A High option volume stocks: WWAV VIPS SIAL AINV A May 14, 2013 16:26 EDT A Agilent CEO sees 2H13 macroeconomic environment "challenging" Subscribe for More Information 16:12 EDT A Agilent raises stock repurchase program to $1B Subscribe for More Information 16:11 EDT A Agilent announces restructuring program, will reduce headcount by about 450 Agilent announced that it has initiated a targeted restructuring program that is expected to reduce Agilent's total headcount by approximately 450 regular employees, representing approximately 2% of its global workforce. The timing and scope of workforce reductions will vary based on local legal requirements. When completed, the restructuring program is expected to result in an approximately $50M reduction in annual operating expenses. 16:09 EDT A Agilent sees FY13 adjusted EPS $2.70-$2.85, consensus $2.88 Subscribe for More Information 16:08 EDT A Agilent sees Q3 adjusted EPS 60c-64c, consensus 74c Subscribe for More Information 16:07 EDT A Agilent raises stock repurchase program to $1B Subscribe for More Information 16:07 EDT A Agilent reports Q2 adjusted EPS 77c, consensus 67c Reports Q2 revenue $1.73B, consensus $1.74B. 15:30 EDT A Notable companies reporting after market close Subscribe for More Information May 13, 2013 15:21 EDT A Agilent May volatility elevated flat into Q2 and outlook Agilent December May call option implied volatility is at 67, June is at 32, August is at 29; compared to its 26-week average of 28 according to Track Data, suggesting large near term price movement into the expected release of Q2 results on May 14. Sign up for a free trial to see the rest of the stories you've been missing.